SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-440575
Filing Date
2013-11-14
Accepted
2013-11-13 19:16:24
Documents
5
Period of Report
2013-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d628546d8k.htm 8-K 14885
2 EX-99.1 d628546dex991.htm EX-99.1 64926
3 GRAPHIC g628546img001.jpg GRAPHIC 18319
4 GRAPHIC g628546img002.jpg GRAPHIC 7535
5 GRAPHIC g628546img003.jpg GRAPHIC 6941
  Complete submission text file 0001193125-13-440575.txt   126548
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35952 | Film No.: 131216179
SIC: 2834 Pharmaceutical Preparations